Skip to content

PrecISE Severe Asthma Interventions

Search Clinical Trials

Trial Objectives


The purpose of this study is to understand how to treat different types of severe asthma using precision medicine. Precision medicine is an approach that targets treatments to defined subgroups of patients who share similar characteristics. For example, patients who have a certain genetic variation or patients with high number of blood eosinophils. Study participants will receive several treatments based on their type of severe asthma for research purposes.

Who Can Participate


Individuals 12 years of age and older whose asthma symptoms are not well-controlled on high dose of inhaled corticosteroids, including those who have frequent asthma attacks.

Age: 12+ Gender Any

Estimated Time Commitment


3 phases, approximately 9 visits per phase for up to 2 years

Payment & Reimbursement


Payment Provided

Travel Reimbursement Not Available

Trial Contact


For more information, contact:

Allen Stevens
303.398.1443

 

Michael White
303.398.1417

Request More Information

Trial Location


National Jewish Main Campus, Denver, CO

Trial Sponsors


National Institutes of Health

Principal Investigators

Michael E. Wechsler

Michael E. Wechsler, MD, MMSc

Co-Investigators

  • Rafeul Alam

    Rafeul Alam, MD, PhD

  • Ronina A. Covar

    Ronina A. Covar, MD

  • Vamsi P. Guntur

    Vamsi P. Guntur, MD, MSc

  • Laurie A. Manka

    Laurie A. Manka, MD

  • Pamela L. Zeitlin

    Pamela L. Zeitlin, MD, MPhil, PhD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health required